"Rumah Sakit Umum Daerah yang dikelola oleh pemerintahan Provinsi Jawa Timur dengan Pelayanan 24 Jam dan menangani pasien dengan berbagai jenis penyakit. Kami mempunyai kapasitas 1600 tempat tidur"

During the past decade, Dr. Soetomo General Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dr. Soetomo General Hospital" #1 sponsor was "Dr. Soetomo General Hospital" with 8 trials, followed by "Ina-Respond" with 3 trials sponsored, "Kirby Institute" with 1 trials sponsored, "National Institute of Health Research and Development, Ministry of Health Republic of Indonesia" with 1 trials sponsored and "Picterus AS" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dr. Soetomo General Hospital" #1 collaborator was "Universitas Airlangga" with 3 trials as a collaborator, "Biotis Pharmaceuticals, Indonesia" with 2 trials as a collaborator, "Indonesia-MoH" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator and "Airlangga University" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Dr. Soetomo General Hospital" are "COVID-19 Pandemic" (2 trials), "Anxiety" (1 trials), "Bone Loss" (1 trials), "Burnout, Psychological" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Dr. Soetomo General Hospital" in a lesser frequency.

Most popular intervention types in "Dr. Soetomo General Hospital" are "Biological" (4 trials), "Other" (4 trials), "Drug" (3 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "CoronaVac Biofarma COVID-19 Vaccine" (2 trials), "Beraprost Sodium" (1 trials), "Best Support Treatment" (1 trials), "Convalescent plasma treatment" (1 trials) and "Darunavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr. Soetomo General Hospital" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Dr. Soetomo General Hospital". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Dr. Soetomo General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dr. Soetomo General Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".

Dr. Soetomo General Hospital has several departments that took part in Clinical trials: "Child Health Dept. Dr. Soetomo Hospital, School of Medicine Airlangga Univ." - 2 trials